Annals of Oncology 13:483, 2002
© 2002 European Society for Medical Oncology
Letters to the Editor |
Humoral immune response for early diagnosis of breast carcinoma
Molecular targeting Unit, Department of Experimental Oncology, Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan; 1Institute of Pathology, University of Milan, Italy (E-mail: menard@istitutotumori.mi.it)
Mortality from cancer, in particular breast carcinomas, has decreased in the last decade, due principally to early diagnosis of the disease. A major effort to improve diagnosis further by identifying serological markers indicative of early-stage disease has met with little success, except for a
References
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. M. Pupa, S. Giuffre, F. Castiglioni, L. Bertola, M. Cantu, I. Bongarzone, P. Baldassari, R. Mortarini, W. S. Argraves, A. Anichini, et al. Regulation of Breast Cancer Response to Chemotherapy by Fibulin-1 Cancer Res., May 1, 2007; 67(9): 4271 - 4277. [Abstract] [Full Text] [PDF] |
||||
